Skip to main content
. 2016 Oct 27;33(12):901–912. doi: 10.1007/s40266-016-0409-7

Table 5.

Discontinuations due to adverse events by age group—treated patients

Age group (years) Fentanyl ITS [n/N (%)] Morphine IV PCA [n/N (%)] Placebo [n/N (%)]
<65 58/1264 (4.6) 64/931 (6.9) 5/250 (2.0)
65–74 11/325 (3.4) 11/234 (4.7) 3/44 (6.8)
75–84 7/158 (4.4) 11/135 (8.1) 0
≥85 1/16 (6.3) 1/13 (7.7) 0

CI confidence interval, ITS iontophoretic transdermal system, IV PCA intravenous patient-controlled analgesia